HEMATOLOGY PROFILES AND DISEASE SEVERITY OF PEDIATRIC DENGUE VIRUS INFECTION AT A TERTIARY HOSPITAL IN SURABAYA, INDONESIA
Downloads
Highlights
- Dengue virus infections exhibit a spectrum of clinical manifestations, ranging from asymptomatic cases to severe disease, with the potential for fatalities if not managed effectively.
- Hematology factors significantly contribute to the severity of dengue virus infection.
Abstract
Background: The escalating incidence of dengue cases in Surabaya, Indonesia, underscores the imperative to comprehend the hematology profiles and disease severity in pediatric patients affected by dengue virus infections (DVI). As the prevalence of DVI continues to surge, understanding the nuanced clinical manifestations becomes paramount for effective management and mitigation of the disease burden. Objective: This study aimed to characterize the hematology profiles and the disease severity of dengue virus infections (DVI) among pediatric patients hospitalized at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia throughout 2019. Material and Method: A retrospective descriptive cross-sectional study was conducted using secondary data from medical records. Pediatric patients aged six months to 18 years were enrolled. A total sampling method comprised 67 patients meeting the inclusion criteria. Result: Severe thrombocytopenia was most commonly observed in dengue hemorrhagic fever (DHF) III cases (36.4%), while leukopenia was predominant in DF cases (42.2%). High hematocrit levels were more prevalent in DHF III cases (27.3%), and high hemoglobin levels were most frequently identified in DHF II and DHF III cases (33% in each case). Significant differences in DVI severity were observed in platelets and hemoglobin levels (p=0.0002 and p=0.0066, respectively) but not in leukocyte and hematocrit levels. Conclusion: Mild thrombocytopenia was prevalent in Dengue Fever (DF), while severe thrombocytopenia was most prevalent in Dengue Hemorrhagic Fever (DHF) grade III. Leukopenia was prominent in DF patients, and platelets and hemoglobin levels varied across severity of DVI. These findings provide insights for improved clinical management and diagnostic criteria refinement.
Aini, Z. M., Arimaswati, A., Rezika, M. F. 2016. Hubungan rerata hasil pemeriksaan laboratorium terhadap derajat klinis infeksi virus dengue pada pasien anak di Rumah Sakit Santa Anna Tahun 2016. Seminar Nasional Teknologi Terapan Berbasis Kearifan Lokal, 2(1): 517–522. Available at: http://ojs.uho.ac.id/index.php/snt2bkl/article/download/9725/7055.
Bhatt, P., Sabeena, S. P., Varma, M., et al. 2021. Current understanding of the pathogenesis of dengue virus infection. Current Microbiology, 78(1): 17–32. doi: 10.1007/s00284-020-02284-w.
Buntubatu, S., Arguni, E., Indrawanti, R., et al. 2017. Status nutrisi sebagai faktor risiko sindrom syok dengue. Sari Pediatri, 18(3): 226. doi: 10.14238/sp18.3.2016.226-32.
Chaloemwong, J., Tantiworawit, A., Rattanathammethee, T., et al. 2018. Useful clinical features and hematological parameters for the diagnosis of dengue infection in patients with acute febrile illness: a retrospective study. BMC Hematology, 18(1): 20. doi: 10.1186/s12878-018-0116-1.
Chong, V., Tan, J. Z. L., Arasoo, V. J. T. 2023. Dengue in pregnancy: A Southeast Asian perspective. Tropical Medicine and Infectious Disease, 8(2): 86. doi: 10.3390/tropicalmed8020086.
Giri, R., Agarwal, K., Verma, S., et al. 2016. A study to correlate level of thrombocytopenia with dengue seropositive patients and frequency of bleeding pattern. Scholars Journal of Applied Medical Sciences (SJAMS), 4(1c): 214–218. doi: 10.36347/sjams.2016.v04i01.040.
Guillena, J. B., Opena, E. L. L., Baguio, M. L. 2013. Prevalence of dengue fever (DF) and dengue hemorrhagic fever (DHF): A description and forecasting in Iligan City, Philippines. Mindanao Journal of Science and Technology, 11(1). Available at: https://ejournals.ph/article.php?id=10502.
Handayani, N. M. D., Udiyani, D. P. C., Mahayani, N. P. A. 2022. Hubungan kadar trombosit, hematokrit, dan hemoglobin dengan derajat demam berdarah dengue pada pasien anak yang rawat inap di BRSU Tabanan. AMJ (Aesculapius Medical Journal), 2(2): 130–136. Available at: https://www.ejournal.warmadewa.ac.id/index.php/amj/article/view/5304.
Hidayat., Triwahyuni, T., Zulfian, Z., et al. 2021. Comparison of hematological abnormalities between primary and secondary dengue infection patient at Regional General Hospital Dr. H. Abdul Moeloek, Lampung. Jurnal Ilmu dan Teknologi Kesehatan Terpadu (JITKT), 1(1): 28–37. doi: 10.53579/jitkt.v1i1.9.
IBM Corp. 2019. IBM SPSS statistics for windows, version 26.0. Armonk, NY: IBM Corp
Kusdianto, M. M., Asmin, E., Latuconsina, V. Z. 2021. Hubungan jumlah hematokrit dan trombosit dengan derajat keparahan pasien infeksi dengue di RSUD DR. M. Haulussy Ambon periode 2019. PAMERI: Pattimura Medical Review, 2(2): 127–144. doi: 10.30598/pamerivol2issue2page127-144.
Laily, F. I., Rossyanti, L., Sulistiawati. 2020. The effect of DHF education on DHF prevention knowledge of 5th and 6th grade students of SDN Purwotengah II Mojokerto. Juxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga, 11(2): 51-55. doi: 10.20473/juxta.V11I22020.51-55.
Laoprasopwattana, K., Binsaai, J., Pruekprasert, P., et al. 2017. Prothrombin time prolongation was the most important indicator of severe bleeding in children with severe dengue viral infection. Journal of Tropical Pediatrics, 63(4): 314–320. doi: 10.1093/tropej/fmw097.
Lorensia, A., Ikawati, Z., Andayani, T. M., et al. 2016. Post-therapy leukocytosis events after intravenous aminophylline compared to the nebulized salbutamol in asthma exacerbations patients. Indonesian Journal of Clinical Pharmacy, 5(3): 149–159. doi: 10.15416/ijcp.2016.5.3.149.
Marvianto, D., Ratih, O. D., Nadya Wijaya, K. F. 2023. Infeksi dengue sekunder: Patofisiologi, diagnosis, dan implikasi klinis. Cermin Dunia Kedokteran, 50(2): 70–74. doi: 10.55175/cdk.v50i2.518.
Masihor, J. J. G., Mantik, M. F. J., Memah, M., et al. 2013. Hubungan jumlah trombosit dan jumlah leukosit pada pasien anak demam berdarah dengue. e-Biomedik, 1(1). doi: 10.35790/ebm.1.1.2013.4152.
Mikhael, K., Husada, D., Lestari, P., 2022. Profile of dengue fever complication in infant at Tertiary Referral Hospital in East Java, Indonesia. Biomolecular and Health Science Journal, 5(1): 11–15. doi: 10.20473/bhsj.v5i1.34827.
Minister of Health of The Republic of Indonesia. 2019. Profil kesehatan Indonesia tahun 2019. Jakarta: Kementerian Kesehatan Republik Indonesia. Available at: https://www.kemkes.go.id/app_asset/file_content_download/Profil-Kesehatan-Indonesia-2019.pdf.
Ralapanawa, U., Alawattegama, A. T. M., Gunrathne, M., et al. 2018. Value of peripheral blood count for dengue severity prediction. BMC Research Notes, 11(1): 400. doi: 10.1186/s13104-018-3505-4.
Riley, L. K., Rupert, J. 2015. Evaluation of patients with leukocytosis. American Family Physician, 92(11): 1004–11. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26760415.
Rosenberger, K. D., Lum, L., Alexander, N., et al. 2016. Vascular leakage in dengue – clinical spectrum and influence of parenteral fluid therapy. Tropical Medicine & International Health, 21(3): 445–453. doi: 10.1111/tmi.12666.
Silitonga, P., Dewi, B. E., Bustamam, A., et al. 2020. Correlation between laboratory characteristics and clinical degree of dengue as an initial stage in a development of machine learning predictor program. in, p. 030008. doi: 10.1063/5.0023932.
Surabaya City Health Office. 2020. Profil kesehatan 2019. Surabaya. Available at: https://dinkes.surabaya.go.id/portalv2/dokumen/Profil Kesehatan Kota Surabaya 2019.pdf.
Vebriani, L., Wardana, Z., Fridayenti. 2016. Karakteristik hematologi pasien demam berdarah dengue di bagian penyakit dalam RSUD Arifin Achmad Provinsi Riau periode 1 Januari – 31 Desember 2013. Jurnal Online Mahasiswa Fakultas Kedokteran Universitas Riau, 3(1). Available at: https://www.neliti.com/id/publications/189003/karakteristik-hematologi-pasien-demam-berdarah-dengue-di-bagian-penyakit-dalam-r.
Wardhani, P., Yohan, B., Tanzilia, M., et al. 2023, Genetic characterization of dengue virus 4 complete genomes from East Java, Indonesia. Virus Genes, 59(1): 36-44. doi: 10.1007/s11262-022-01942-4.
Wisanti, R., Gonga, V. N., Hartanto, W., et al. 2022. Referat jumlah leukosit sebagai prediktor perburukan trombositopenia pada pasien demam dengue anak. Jurnal Health Sains, 3(2): 289–297. doi: 10.46799/jhs.v3i2.426.
World Health Organization. 2022. Guidelines for the clinical diagnosis and treatment of Dengue, Chikungunya, and Zika. WHO. Available at: https://www.who.int/publications/i/item/978927 5124871.
World Health Organization. 2023. Dengue and severe dengue. WHO. Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
Yanti, E. L., Suryawan, I. W. B., Widiasa, M. 2021. Hubungan derajat leukopenia terhadap tingkat keparahan penyakit Demam Berdarah Dengue (DBD) pada pasien anak yang dirawat di Ruang Kaswari RSUD Wangaya, Denpasar, Indonesia. Intisari Sains Medis, 12(3): 908–911. doi: 10.15562/ism.v12i3.1160.
Copyright (c) 2024 Annisa Fira Salsabila, Juniastuti, Dominicus Husada, Dwiyanti Puspitasari
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author(s) to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International License (CC-BY).
